Advertisement

Buy track record

How this insider's open-market purchases have performed
8%
of buys now in profit
1 up · 12 down
Avg return since buy−92.1%
Median return−99.9%
Best trade+1.7%
Worst trade−99.9%
Buys scored13
Average return by holding period — separates good entry timing from riding one long winner
After 1 month +1.0% 8% won · 13 trades
After 3 months −0.1% 0% won · 13 trades
After 6 months +0.0% 0% won · 12 trades
After 12 months +0.0% 0% won · 12 trades
DateCompany90d trendBuy priceValueΔOwn1M3M6M12MTo date
Mar 2, 2026 GENB $16 $25M NEW +13.0% −1.6% +1.7%
Jan 30, 2013 BGMD $2 $500K +11% +0.0% +0.0% +0.0% +0.0% −99.9%
Jan 30, 2013 BGMD $2 $250K +24% +0.0% +0.0% +0.0% +0.0% −99.9%
Jan 30, 2013 BGMD $2 $150K +54% +0.0% +0.0% +0.0% +0.0% −99.9%
Jan 30, 2013 BGMD $2 $1M +21% +0.0% +0.0% +0.0% +0.0% −99.9%
Jan 30, 2013 BGMD $2 $2.1M +147% +0.0% +0.0% +0.0% +0.0% −99.9%
Feb 9, 2011 BGMD $7 $250K +7.3% +0.0% +0.0% +0.0% +0.0% −99.9%
Feb 9, 2011 BGMD $7 $75K +3.7% +0.0% +0.0% +0.0% +0.0% −99.9%
Feb 9, 2011 BGMD $7 $150K +30% +0.0% +0.0% +0.0% +0.0% −99.9%
Feb 9, 2011 BGMD $7 $100K +11% +0.0% +0.0% +0.0% +0.0% −99.9%
Feb 9, 2011 BGMD $7 $1.9M +13% +0.0% +0.0% +0.0% +0.0% −99.9%
Feb 9, 2011 BGMD $7 $300K +2.0% +0.0% +0.0% +0.0% +0.0% −99.9%
Feb 9, 2011 BGMD $7 $5M NEW +0.0% +0.0% +0.0% +0.0% −99.9%
How this is calculated. We score only open-market purchases (SEC code P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 13 scored trades, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$36.78M
13 trades
Open-market sells
$106.91M
166 trades
Net flow
−$70.14M
Net selling
Total filings
183
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 29, 2024 ΔOwn −0.1%

Afeyan Noubar sold $117.4K of MRNA.

−$117.4K
1,100 sh @ $107
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 29, 2024 ΔOwn −0.1%

Afeyan Noubar sold $158K of MRNA.

−$158K
1,466 sh @ $108
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 29, 2024 ΔOwn −0.1%

Afeyan Noubar sold $338.2K of MRNA.

−$338.2K
3,100 sh @ $109
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 29, 2024 ΔOwn −0.2%

Afeyan Noubar sold $500.9K of MRNA.

−$500.9K
4,544 sh @ $110
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 29, 2024 ΔOwn −0.1%

Afeyan Noubar sold $329.3K of MRNA.

−$329.3K
2,973 sh @ $111
Advertisement
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 22, 2024 ΔOwn −0.1%

Afeyan Noubar sold $213.5K of MRNA.

−$213.5K
2,113 sh @ $101
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 22, 2024 ΔOwn −0.3%

Afeyan Noubar sold $726.2K of MRNA.

−$726.2K
7,109 sh @ $102
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 22, 2024 ΔOwn −0.3%

Afeyan Noubar sold $596.1K of MRNA.

−$596.1K
5,778 sh @ $103
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 15, 2024 ΔOwn −0.3%

Afeyan Noubar sold $669.5K of MRNA.

−$669.5K
6,281 sh @ $107
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 15, 2024 ΔOwn −0.1%

Afeyan Noubar sold $247.6K of MRNA.

−$247.6K
2,300 sh @ $108
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 15, 2024

Afeyan Noubar sold $65.1K of MRNA.

−$65.1K
600 sh @ $109
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 15, 2024

Afeyan Noubar sold $45.1K of MRNA.

−$45.1K
412 sh @ $109
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 15, 2024 ΔOwn −0.2%

Afeyan Noubar sold $421.4K of MRNA.

−$421.4K
3,803 sh @ $111
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 15, 2024 ΔOwn −0.1%

Afeyan Noubar sold $156.8K of MRNA.

−$156.8K
1,404 sh @ $112
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 15, 2024

Afeyan Noubar sold $22.5K of MRNA.

−$22.5K
200 sh @ $112
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Nov 3, 2023 ΔOwn −0.1%

Afeyan Noubar sold $143.1K of MRNA.

−$143.1K
1,900 sh @ $75
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Nov 3, 2023 ΔOwn −0.4%

Afeyan Noubar sold $617K of MRNA.

−$617K
8,100 sh @ $76
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 27, 2023 ΔOwn −0.3%

Afeyan Noubar sold $498.7K of MRNA.

−$498.7K
6,500 sh @ $77
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 27, 2023 ΔOwn −0.1%

Afeyan Noubar sold $239.8K of MRNA.

−$239.8K
3,100 sh @ $77
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 27, 2023

Afeyan Noubar sold $31.4K of MRNA.

−$31.4K
400 sh @ $78
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 13, 2023 ΔOwn −0.4%

Afeyan Noubar sold $895.1K of MRNA.

−$895.1K
8,700 sh @ $103
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 13, 2023 ΔOwn −0.3%

Afeyan Noubar sold $591.4K of MRNA.

−$591.4K
5,700 sh @ $104
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 13, 2023

Afeyan Noubar sold $52.4K of MRNA.

−$52.4K
500 sh @ $105
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 13, 2023

Afeyan Noubar sold $10.6K of MRNA.

−$10.6K
100 sh @ $106
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 6, 2023

Afeyan Noubar sold $103K of MRNA.

−$103K
1,030 sh @ $100
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 6, 2023 ΔOwn −0.1%

Afeyan Noubar sold $181.7K of MRNA.

−$181.7K
1,800 sh @ $101
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 6, 2023 ΔOwn −0.1%

Afeyan Noubar sold $275.5K of MRNA.

−$275.5K
2,700 sh @ $102
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 6, 2023 ΔOwn −0.3%

Afeyan Noubar sold $578.4K of MRNA.

−$578.4K
5,604 sh @ $103
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Oct 6, 2023 ΔOwn −0.2%

Afeyan Noubar sold $402.2K of MRNA.

−$402.2K
3,866 sh @ $104
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Sep 29, 2023 ΔOwn −0.2%

Afeyan Noubar sold $512.4K of MRNA.

−$512.4K
5,204 sh @ $98

Frequently asked questions

How is AFEYAN NOUBAR's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from AFEYAN NOUBAR's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.